Rigel Pharmaceuticals (RIGL)
(Real Time Quote from BATS)
$1.08 USD
-0.05 (-4.00%)
Updated Apr 25, 2024 11:13 AM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/7/24 |
---|---|
Current Quarter | -0.03 |
EPS Last Quarter | 0.00 |
Last EPS Surprise | 100.00% |
ABR | 2.33 |
Earnings ESP
|
-9.09% |
---|---|
Current Year | -0.05 |
Next Year | 0.06 |
EPS (TTM) | -0.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 31.28M | 31.46M | 147.19M | 186.34M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 32.41M | 33.79M | 154.90M | 198.94M |
Low Estimate | 30.17M | 28.16M | 136.40M | 160.00M |
Year ago Sales | 26.07M | 26.89M | 116.88M | 147.19M |
Year over Year Growth Est. | 19.98% | 16.98% | 25.93% | 26.60% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.03 | -0.03 | -0.05 | 0.06 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.03 | -0.03 | -0.04 | -0.02 |
High Estimate | -0.01 | -0.02 | 0.04 | 0.13 |
Low Estimate | -0.04 | -0.04 | -0.13 | -0.02 |
Year ago EPS | -0.08 | -0.04 | -0.14 | -0.05 |
Year over Year Growth Est. | 62.50% | 25.00% | 64.29% | 214.00% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.03 | -0.03 | -0.05 | 0.06 |
7 Days Ago | -0.03 | -0.03 | -0.05 | 0.06 |
30 Days Ago | -0.03 | -0.03 | -0.06 | 0.03 |
60 Days Ago | -0.05 | -0.03 | -0.08 | 0.02 |
90 Days Ago | -0.05 | -0.03 | -0.08 | -0.02 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.03 | -0.03 | -0.03 | 0.13 |
Zacks Consensus Estimate | -0.03 | -0.03 | -0.05 | 0.06 |
Earnings ESP | -9.09% | 0.00% | 42.31% | 136.36% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.00 | -0.03 | -0.04 | -0.08 | NA |
Estimate | -0.03 | -0.07 | -0.08 | -0.09 | NA |
Difference | 0.03 | 0.04 | 0.04 | 0.01 | 0.03 |
Surprise | 100.00% | 57.14% | 50.00% | 11.11% | 54.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more